Normally after a large rise of media on speculation there is a refuting RNS saying that there are no grounds in it. It looks like they mabe something in the Anglo American deal as EUA has NOT refuted the news leak.,
I`ve just been offered 3.1p
Listen to the end of the video. https://www.youtube.com/watch?v=UGlZ9Udw7bE
Looking at todays buying, its looking like a blue finish. What do you all think?
Will be a very interesting day for the airlines. https://www.bbc.co.uk/news/uk-55052381
88 Energy Limited
Peregrine Farm-Out Progresses - Preferred Bidder Selected
88 Energy Limited ("88 Energy" or the "Company", ASX:88E, AIM 88E) is pleased to provide the following update related to the farm-out at its Project Peregrine, on the North Slope of Alaska.
Highlights
· Multiple bids received
· Preferred bidder selected and preparation of final documentation underway
· Transaction close and execution of documents expected within weeks
Detail
The farm-out process at Project Peregrine has progressed to the final phase and is subject only to finalisation of standard documentation as the preferred bidder has now been selected. Strong interest was shown in the opportunity and the bids received were competitive. Execution of the final documents is expected in the next few weeks, at which point more detail on the transaction will be made public. However, the Company advises that there is no guarantee that the parties will agree final terms and conclude the transaction. A further announcement will be made in due course on the outcome of the ongoing discussions, which are currently confidential in nature.
Planning and permitting remains on schedule for a late February 2021 spud of the first well at Project Peregrine.
Managing Director of 88 Energy, Dave Wall, stated: "The strong interest shown in the imminent drilling program at Project Peregrine is both a testament to the quality of the opportunity and the hard work done by the 88E team over the last few months. We look forward to working with the preferred bidder to close the transaction and get going on the drill program."
This announcement has been authorised by the Board.
IQ-AI Ltd
("IQ-AI" or the "Company")
IB and the Mayo Clinic Enter into an Agreement to Develop IB Trax™
Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI, Ltd, has entered into an agreement (the "Agreement") with Mayo Clinic to develop a brain lesion tracking platform, IB Trax. The collaboration's objective is the development of an innovative AI technology to track metastatic and primary brain tumours. IB's proven quantitative technologies will form the foundation of IB Trax and the overall workflow will receive direct clinical input from the Mayo Clinic.
This Agreement considerably expands the existing relationship between IB and the Mayo Clinic by appointing Dr. Leland Hu, MD, an Assistant Professor of Radiology at the Mayo Clinic Arizona, to IB's Scientific Advisory Board.
Under the terms of the Agreement, IQ-AI will issue Mayo Clinic a token of $50,000 of shares in IQ-AI at a price equivalent to the three-month average share price prior to the effective date of the Agreement. In addition, IQ-AI will issue the Mayo Clinic, $10,000 of shares in IQ-AI at a price equivalent to the three-month average share price prior to the date the shares are issued, on the first anniversary and every successive year whilst the agreement is in existence. In addition, the Mayo Clinic will receive a 4% on-going royalty on each sale of IB Trax, including $20,000 on the initial commercial installation.
Ultimately, the aim is to leverage IB's existing quantitative solutions and AI expertise to develop a streamlined workflow that systematically identifies, tracks, and reports changes to brain lesions. Currently, the way clinicians perform this task is cumbersome and subjective. The Mayo Clinic is ideally positioned to assist in this effort as it is renowned for excellence and commonly treats the most challenging of brain tumour cases from around the world.
"We are excited to team up with the Mayo Clinic to significantly expand the diagnostic utility of our core applications. This collaboration provides key clinical input to further enhance the design and guide development of IB Trax," said Michael Schmainda, CEO of IB.
Trevor Brown CEO of IQAI, commented, "IB have now entered a period of exponential growth in their development of innovative medical AI technologies."
The Directors of the Company accept responsibility for the contents of this announcement.
Rare Earths Co-Development Project in South Africa
Rainbow Rare Earths is pleased to announce the signing of a binding Agreement for Co-Development (the "Agreement") of the Phalaborwa Rare Earths Project (the "Project"), located in South Africa, with Bosveld Phosphates (Pty) Ltd ("Bosveld"). The Project comprises approximately 35 million tonnes of gypsum resulting from historic phosphate hard rock mining, containing rare earth elements ("REE") with an estimated average in situ grade of 0.6% Total Rare Earth Oxides ("TREO"), based on previous sampling campaigns.
Project highlights
· Rainbow and Bosveld intend to jointly develop and process rare earth elements from the gypsum contained in two stacks at the Project site (the "Gypsum Stacks").
· Initial grab sample assays from the c. 35 million tonnes Gypsum Stacks indicate 0.6% TREO, indicating c. 210,000 tonnes of contained TREOs, with Neodymium (Nd) and Praseodymium (Pr) (together "NdPr") anticipated to constitute c. 30% of the TREO basket.
· The unique nature of these Gypsum Stacks results from the historic concentration of REEs during Foskor's flotation process, followed by further upgrading in Sasol's PhosAcid Plant, leading to REE concentration in chemical (rather than mineral) form, which enables simpler onward processing.
· Sasol developed a comprehensive process flowsheet to extract the rare earths from the gypsum, which resulted in a successful pilot plant operation, producing c. 3 tonnes of mixed rare earth carbonate at c. 80% recoveries.
· Initial reports suggest low levels of radioactive elements, similar to those seen at Rainbow's Gakara Project, in Burundi.
· The Project is fully permitted, with an Environmental Impact Assessment completed.
· The re-processing of these Gypsum Stacks carries significant environmental benefits in that it will redeposit clean, benign gypsum, which then has the potential for further use in the building and fertiliser industries.
Key terms of the Agreement
· A total consideration of US$750,000, in a combination of cash and shares (priced based on the prevailing Rainbow share price on date of issue), shall be paid by Rainbow to Bosveld in three equal tranches over twelve months, with the first tranche being payable after completion of an initial due diligence process. The due diligence process is expected to last up to 35 days and a further announcement will be made on completion of the due diligence process.
· On completion of the pre-feasibility study ("PFS"), 70% of the Project will held by Rainbow and 30% by Bosveld, with a mechanism included to allow for Rainbow's Joint Venture ownership to vary from 60% to 85%, dependent on results of the PFS.
George Bennett, CEO, said: "This Joint Venture represents an important and exciting step in Rainbow's strategy to benefit from the expected growth in global demand for rare earth metals. The considerable amounts of historical test work